
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.
He likes the life insurance industry and owns three companies in that space. Sun Life is the Canadian company that he likes. He prefers it to Manulife. He thinks it is better managed, with better exposure to interest rates. He likes the amount and quality of international diversification of Sun Life.
Life Insurance companies do better when interest rates rise because they reinvest their premiums, mainly in the bond market. Interest rates have not increased as much as he hoped; instead, the yield curve is flattening. He expects interest rates to rise in the future, though, and he owns Sun Life in that expectation. He thinks that over the near term, Sun Life will perform better than the Canadian banks as interest rates move up. Interest rates will rise because the economy is doing better and inflation is coming back, caused by labour shortages and tariffs.
Manulife (MFC-T) versus Sunlife (SLF-T). He owned Manulife going into the financial crisis, but became concerned about management and sold out of their holdings. When Sunlife began to fall in sympathy they bought them – focusing on the preferred shares in particular. Manulife still has some questionable assets in the US and may not know how to offload them.
He likes lifecos for the long haul because society is aging for longer, so the lifecos defer their payouts longer. However, profitability in this business lies in the long-term disability sector, but no company now has a competitive advantage here. Look out for the one that does by reading their reports for what they say about disability insurance management.
He considers this a healthy yield that is likely to grown. It trades at only 11x earnings. It will be a beneficiary of rising interest rates, which he expects to continue. He expects 10% earnings growth for the next 3 years. This is the largest foreign insurer in Asia (India), which offers huge growth possibilities. Its MFS American operations have turned around. Yield 3.8%. (Analysts’ price target $58.54)